The scale of the problem was highlighted in March when authorities set ablaze $645 million worth of counterfeit medicines ...

The scale of the problem was highlighted in March when authorities set ablaze $645 million worth of counterfeit medicines ...

It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize ... As of April 2, 2025, Amicus ...

Patrick Vallance's appointment was politically foolish and deeply alarming given his role in a shocking conspiracy that has ...

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

Porous borders and weak regulations ... leaving a void in the market. US giant Pfizer recently shuttered its operations in the country, while British multinational GlaxoSmithKline and French ...

During the restructuring process, 23andMe obtained up to $35 million in debtor-in-possession finance to assist operations as ...

The organization eventually verified that the assailants had used a credential-stuffing weakness to gain access ... Now trading with a market value of $16.8 million, the company's shares has ...

Something seems to be going awry with GlaxoSmithKline's game plan for ... respectively 32 and 35 per cent shy of analyst predictions. Weakness in the respiratory franchise - along with what ...

When Prince Amuniwaiye ascended the throne of his fathers, it looked like he would do well. Oyo had looked forward to a new ...

Stock Market Today: Nifty-50 Index managed to end ... For Bank Nifty, unless the index reclaims 48,500 on a closing basis, ...